An allosteric AMPK activator A-769662 has been described to act independently of the upstream AMPK kinases, inhibiting AMPK dephosphorylation [26] and to decrease plasma glucose and triglyceride levels in a mouse diabetes model ob/ob mice [27]. Here, PRKAB1 is linked to diabetes mellitus.